FDA Warns About Johnson & Johnson COVID Vaccine and Guillain-Barré Syndrome Risk—Here's What That Means

2021-07-14 13 Dailymotion

Of the 100 preliminary reports of Guillain-Barré syndrome, 95 were serious.

Related Videos

More Than 500,000 At-Home COVID Tests Recalled, FDA Warns of Bacteria Risk

What to Know About At-Home COVID-19 Tests After FDA Warns Against Them

This TikTok User Says He Developed Guillain-Barré Syndrome After Having COVID-19—How Can That Happen?

FDA Warns Nitrate Poppers Cause 'Serious Adverse Health Effects

WHO Warns Against Mixing COVID Vaccines—Here's What We Know So Far

What Is an Endemic Virus? WHO Warns COVID-19 'May Never Go Away'

Dr. Fauci Warns That These 3 Businesses Should Close in Many Places to Prevent a COVID-19

CDC Director Warns of ‘Impending Doom’ as COVID-19 Cases Increase Across the US

FDA Approves the Pfizer Vaccine, Now Called Comirnaty—Here's What FDA Approval Means

FDA Panel Recommends Johnson & Johnson Booster Shot—Here's What Happens Next